Inventor
WANG CHANGYU
US29 patents
⚠️ This page may combine multiple inventors who share the name “WANG CHANGYU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SQUIBB & SONS LLC
9 patentsUS9580507B2Feb 28, 2017
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
SQUIBB & SONS LLC129 citations99
US9492540B2Nov 15, 2016
Methods for treating cancer using anti-PD-1 antibodies
SQUIBB & SONS LLC139 citations99
US9492539B2Nov 15, 2016
Monoclonal antibodies to Programmed Death 1 (PD-1)
SQUIBB & SONS LLC119 citations99
US9387247B2Jul 12, 2016
Monoclonal antibodies to programmed death 1 (PD-1)
SQUIBB & SONS LLC124 citations99
US9358289B2Jun 7, 2016
Methods for treating cancer using anti-PD-1 antibodies in combination with anti-CTLA-4 antibodies
SQUIBB & SONS LLC137 citations99
US9273135B2Mar 1, 2016
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
SQUIBB & SONS LLC109 citations99
US9580505B2Feb 28, 2017
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
SQUIBB & SONS LLC37 citations98
US10441655B2Oct 15, 2019
Monoclonal antibodies to programmed death 1 (PD-1)
SQUIBB & SONS LLC25 citations94
US9994633B2Jun 12, 2018
IP-10 antibodies and their uses
SQUIBB & SONS LLC1 citations60
BRISTOL MYERS SQUIBB CO
9 patentsUS9228016B2Jan 5, 2016
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
BRISTOL MYERS SQUIBB CO85 citations98
US10465010B2Nov 5, 2019
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
BRISTOL MYERS SQUIBB CO9 citations92
US9745379B2Aug 29, 2017
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
BRISTOL MYERS SQUIBB CO11 citations92
US11084881B2Aug 10, 2021
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
BRISTOL MYERS SQUIBB CO3 citations84
US10501550B2Dec 10, 2019
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
BRISTOL MYERS SQUIBB CO9 citations84
US11213586B2Jan 4, 2022
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)
BRISTOL MYERS SQUIBB CO5 citations72
US10690674B2Jun 23, 2020
Anti-GITR antibodies for cancer diagnostics
BRISTOL MYERS SQUIBB CO5 citations71
US11802162B2Oct 31, 2023
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
BRISTOL MYERS SQUIBB CO0 citations62
US11408889B2Aug 9, 2022
Anti-GITR antibodies for cancer diagnostics
BRISTOL MYERS SQUIBB CO1 citations61
MEDAREX INC
4 patentsUS9102725B2Aug 11, 2015
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
MEDAREX INC120 citations99
US8383796B2Feb 26, 2013
Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)
MEDAREX INC355 citations99
US8008449B2Aug 30, 2011
Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
MEDAREX INC2,199 citations99
US7943743B2May 17, 2011
Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
MEDAREX INC1,485 citations99